Search Results
PARP inhibitor rechallenging in ovarian cancer
Dr. Penson on Re-Challenging With PARP Inhibition in Ovarian Cancer
Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel Approaches
PARP Inhibition Improves Outcomes in Patients With BRCA-Mutated Ovarian Cancer
Emerging & Promising Clinical Trials in Ovarian Cancer: Learn the Latest
#ESMO21 Highlights on maintenance olaparib in ovarian cancer previously treated with PARPi
PARP Inhibitors in Platinum Sensitive & Platinum Resistant Ovarian Cancers
Should 1L maintenance with PARP inhibitors be given to all patients with ovarian cancer?
The Changing Role of Parp Inhibitors in the Treatment of Ovarian Cancer
Dr. Penson on Biomarkers of Response to PARP Inhibitors in Ovarian Cancer
Chair's Take: Latest and Emerging Evidence of PARP Inhibitors in Ovarian Cancer Management
Update on PARP inhibitors in Ovarian and Pancreatic Cancer
